Overview

Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of he study is to evaluate effects of dexmedetomidine on pain during radiofrequency ablation of liver and kidney tumours.
Phase:
Phase 4
Details
Lead Sponsor:
Uppsala University Hospital
Treatments:
Dexmedetomidine